Cargando…
Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate.
Exposure to di-(2-ethylhexyl) phthalate (DEHP) is prevalent based on the measurement of its hydrolytic metabolite mono-(2-ethylhexyl) phthalate (MEHP) in the urine of 78% of the general U.S. population studied in the 1999-2000 National Health and Nutrition Examination Survey (NHANES). However, despi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241862/ https://www.ncbi.nlm.nih.gov/pubmed/14998748 |
_version_ | 1782125523613253632 |
---|---|
author | Kato, Kayoko Silva, Manori J Reidy, John A Hurtz, Donald Malek, Nicole A Needham, Larry L Nakazawa, Hiroyuki Barr, Dana B Calafat, Antonia M |
author_facet | Kato, Kayoko Silva, Manori J Reidy, John A Hurtz, Donald Malek, Nicole A Needham, Larry L Nakazawa, Hiroyuki Barr, Dana B Calafat, Antonia M |
author_sort | Kato, Kayoko |
collection | PubMed |
description | Exposure to di-(2-ethylhexyl) phthalate (DEHP) is prevalent based on the measurement of its hydrolytic metabolite mono-(2-ethylhexyl) phthalate (MEHP) in the urine of 78% of the general U.S. population studied in the 1999-2000 National Health and Nutrition Examination Survey (NHANES). However, despite the high level of production and use of DEHP, the urinary MEHP levels in the NHANES samples were lower than the monoester metabolites of phthalates less commonly used than DEHP, suggesting metabolic differences between phthalates. We measured MEHP and two oxidative DEHP metabolites, mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) and mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) to verify whether these other metabolites account for a greater proportion of DEHP metabolic products in 127 paired human urine and serum samples. We found that the urinary levels of MEHHP and MEOHP were 10-fold higher than levels of MEHP; concentrations of urinary MEOHP and MEHHP were strongly correlated (r = 0.928). We also found that the serum levels of MEOHP and MEHHP were comparatively lower than those in urine. Furthermore, the glucuronide-bound conjugates of the oxidative metabolites were the predominant form in both urine and serum. MEOHP and MEHHP cannot be formed by serum enzymes from the hydrolysis of any contamination from DEHP potentially introduced during blood collection and storage. Therefore, concentrations of MEHHP and MEOHP in serum may be a more selective measure of DEHP exposure than is MEHP. However, additional data on the absorption, distribution, metabolism, and elimination of these oxidative metabolites are needed to completely understand the extent of DEHP exposure from the serum concentrations of oxidative DEHP metabolites. |
format | Text |
id | pubmed-1241862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
record_format | MEDLINE/PubMed |
spelling | pubmed-12418622005-11-08 Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Kato, Kayoko Silva, Manori J Reidy, John A Hurtz, Donald Malek, Nicole A Needham, Larry L Nakazawa, Hiroyuki Barr, Dana B Calafat, Antonia M Environ Health Perspect Research Article Exposure to di-(2-ethylhexyl) phthalate (DEHP) is prevalent based on the measurement of its hydrolytic metabolite mono-(2-ethylhexyl) phthalate (MEHP) in the urine of 78% of the general U.S. population studied in the 1999-2000 National Health and Nutrition Examination Survey (NHANES). However, despite the high level of production and use of DEHP, the urinary MEHP levels in the NHANES samples were lower than the monoester metabolites of phthalates less commonly used than DEHP, suggesting metabolic differences between phthalates. We measured MEHP and two oxidative DEHP metabolites, mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) and mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) to verify whether these other metabolites account for a greater proportion of DEHP metabolic products in 127 paired human urine and serum samples. We found that the urinary levels of MEHHP and MEOHP were 10-fold higher than levels of MEHP; concentrations of urinary MEOHP and MEHHP were strongly correlated (r = 0.928). We also found that the serum levels of MEOHP and MEHHP were comparatively lower than those in urine. Furthermore, the glucuronide-bound conjugates of the oxidative metabolites were the predominant form in both urine and serum. MEOHP and MEHHP cannot be formed by serum enzymes from the hydrolysis of any contamination from DEHP potentially introduced during blood collection and storage. Therefore, concentrations of MEHHP and MEOHP in serum may be a more selective measure of DEHP exposure than is MEHP. However, additional data on the absorption, distribution, metabolism, and elimination of these oxidative metabolites are needed to completely understand the extent of DEHP exposure from the serum concentrations of oxidative DEHP metabolites. 2004-03 /pmc/articles/PMC1241862/ /pubmed/14998748 Text en |
spellingShingle | Research Article Kato, Kayoko Silva, Manori J Reidy, John A Hurtz, Donald Malek, Nicole A Needham, Larry L Nakazawa, Hiroyuki Barr, Dana B Calafat, Antonia M Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. |
title | Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. |
title_full | Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. |
title_fullStr | Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. |
title_full_unstemmed | Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. |
title_short | Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. |
title_sort | mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241862/ https://www.ncbi.nlm.nih.gov/pubmed/14998748 |
work_keys_str_mv | AT katokayoko mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate AT silvamanorij mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate AT reidyjohna mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate AT hurtzdonald mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate AT maleknicolea mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate AT needhamlarryl mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate AT nakazawahiroyuki mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate AT barrdanab mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate AT calafatantoniam mono2ethyl5hydroxyhexylphthalateandmono2ethyl5oxohexylphthalateasbiomarkersforhumanexposureassessmenttodi2ethylhexylphthalate |